NEW YORK, May 5, 2020 /PRNewswire/ -- Rowley Law PLLC is
investigating potential securities law violations by Portola
Pharmaceuticals, Inc. (NASDAQ: PTLA) and its board of directors
concerning the proposed acquisition of the company by Alexion
Pharmaceuticals, Inc. (NASDAQ: ALXN). Stockholders will receive
$18.00 for each share of Portola
Pharmaceuticals stock that they hold. The transaction is valued at
approximately $1.4 billion and is
expected to close in the third quarter of 2020.
If you are a stockholder of Portola Pharmaceuticals, Inc. and
are interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/ptla. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-portola-pharmaceuticals-inc-301053279.html
SOURCE Rowley Law PLLC